Contineum’s PIPE-307 Fails Phase II MS Trial, Focus Shifts To IPF Candidate

 
• By Sushmita Panda
  
A doctor hold a holographic image of brain in his hand.
Multiple sclerosis (MS) is an inflammatory disease affecting the brain and spinal cord of the Central Nervous System (CNS).
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D